Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 1996 AL 2010

Postulating the possible cellular signalling mechanisms of antibody drug conjugates in Alzheimer's disease

Punyakoti P, Behl T, Sehgal A, Yadav S, Sachdeva M, Anwer MK, Vargas-De-La-Cruz C, Venkatachalam T, Naqvi M, Verma R, Tuli HS.

Cell Signal. 2023 Feb;102:110539. doi: 10.1016/j.cellsig.2022.110539. Epub 2022 Nov 29.

The ameliorative effects and mechanisms of abscisic acid on learning and memory

Liao P, Wu QY, Li S, Hu KB, Liu HL, Wang HY, Long ZY, Lu XM, Wang YT.

Neuropharmacology. 2023 Feb 15;224:109365. doi: 10.1016/j.neuropharm.2022.109365. Epub 2022 Nov 30.

Lecanemab for Alzheimer's disease: tempering hype and hope

The Lancet.

Lancet. 2022 Dec 3;400(10367):1899. doi: 10.1016/S0140-6736(22)02480-1.

The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer's disease

Du H, Meng X, Yao Y, Xu J.

Front Endocrinol (Lausanne). 2022 Nov 17;13:1033479. doi: 10.3389/fendo.2022.1033479. eCollection 2022.

Research Progress of Targeting Neuro-Immune Inflammation in the Treatment of Alzheimer's Disease

Chen H, Deng C, Meng Z, Meng S.

Front Biosci (Landmark Ed). 2022 Nov 25;27(11):312. doi: 10.31083/j.fbl2711312.

Natural Carotenoids as Neuroprotective Agents for Alzheimer's Disease: An Evidence-Based Comprehensive Review

Batool Z, Chen JH, Gao Y, Lu LW, Xu H, Liu B, Wang M, Chen F.

J Agric Food Chem. 2022 Dec 21;70(50):15631-15646. doi: 10.1021/acs.jafc.2c06206. Epub 2022 Dec 8.

Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer's disease

Dhadda S, Kanekiyo M, Li D, Swanson CJ, Irizarry M, Berry S, Kramer LD, Berry DA.

Alzheimers Res Ther. 2022 Dec 9;14(1):182. doi: 10.1186/s13195-022-01129-x.

Beyond the classical amyloid hypothesis in Alzheimer's disease: Molecular insights into current concepts of pathogenesis, therapeutic targets, and study models

Theerasri A, Janpaijit S, Tencomnao T, Prasansuklab A.

WIREs Mech Dis. 2023 Mar;15(2):e1591. doi: 10.1002/wsbm.1591. Epub 2022 Dec 9.

Synthetic, Cell-Derived, Brain-Derived, and Recombinant β-Amyloid: Modelling Alzheimer's Disease for Research and Drug Development

Varshavskaya KB, Mitkevich VA, Makarov AA, Barykin EP.

Int J Mol Sci. 2022 Nov 30;23(23):15036. doi: 10.3390/ijms232315036.

Disease-Modifying Activity of Huperzine A on Alzheimer's Disease: Evidence from Preclinical Studies on Rodent Models

Yan YP, Chen JY, Lu JH.

Int J Mol Sci. 2022 Dec 3;23(23):15238. doi: 10.3390/ijms232315238.

Unmasking BACE1 in aging and age-related diseases

Bao H, Shen Y.

Trends Mol Med. 2023 Feb;29(2):99-111. doi: 10.1016/j.molmed.2022.11.008. Epub 2022 Dec 9.

Emerging therapeutics agents and recent advances in drug repurposing for Alzheimer's disease

Neha, Parvez S.

Ageing Res Rev. 2023 Mar;85:101815. doi: 10.1016/j.arr.2022.101815. Epub 2022 Dec 16.

Lecanemab for Alzheimer's disease

Walsh S, Merrick R, Richard E, Nurock S, Brayne C.

BMJ. 2022 Dec 19;379:o3010. doi: 10.1136/bmj.o3010.

A pragmatic parallel arm randomized-controlled trial of a multi-pronged electronic health record-based clinical decision support tool protocol to reduce low-value antipsychotic prescriptions among older adults with Alzheimer's and related dementias

Mafi JN, Walling AM, Villaflores C, Vangala S, Sorensen A, Cheng E, Turner A, Trutner Z, Cheng G, Arbanas JC, Waterman B, Shu S, Goldstein N, Sarkisian C.

PLoS One. 2022 Dec 20;17(12):e0277409. doi: 10.1371/journal.pone.0277409. eCollection 2022.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias